Neither the quantity of CTCs per mL of blood (p=0.51, Figure 1C) nor the ratio of CTCs to CD45+ immune cells (p=0.79, Figure S2A) significantly differed between 4T1 tumor-bearing mice treated with NPs or saline. The gene discussed is PTPRC; the disease is neoplasm.